Back to BIIB

BIOGEN INC. Stockholders' Equity 2006-2026 | BIIB

Beta

What is stockholders' equity?

Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.

What is BIOGEN INC.'s current stockholders' equity?

BIOGEN INC. (BIIB) annual stockholders' equity for 2025 was $18.26B, a 9.22% increase from 2024. BIOGEN INC. stockholders' equity for the quarter ending March 31, 2026 was $18.65B.

What was BIOGEN INC.'s stockholders' equity in 2024?

BIOGEN INC. annual stockholders' equity for 2024 was $16.72B, a 12.95% increase from 2023.

What was BIOGEN INC.'s stockholders' equity in 2023?

BIOGEN INC. annual stockholders' equity for 2023 was $14.80B, a 10.54% increase from 2022.

What is BIOGEN INC.'s 5-year stockholders' equity CAGR?

BIOGEN INC. stockholders' equity grew at a compound annual growth rate (CAGR) of 11.31% from FY2020 to FY2025, going from $10.69B to $18.26B over 5 years.

Stockholders' Equity History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+11.3%
FY2020
$10.69B
→
FY2025
$18.26B
0607080910111213141516171819202122232425
5 years selected
Stockholders' Equity History
PeriodValueChangeSource
FY2025$18.26B+9.2%10-K
FY2024$16.72B+13.0%10-K
FY2023$14.80B+10.5%10-K
FY2022$13.39B+22.2%10-K
FY2021$10.96B+2.6%10-K
FY2020$10.69B-19.9%10-K
FY2019$13.34B+2.4%10-K
FY2018$13.03B+3.4%10-K
FY2017$12.60B+3.8%10-K
FY2016$12.14B+29.5%10-K
FY2015$9.37B-13.3%10-K
FY2014$10.81B+25.4%10-K
FY2013$8.62B+23.8%10-K
FY2012$6.96B+8.4%10-K
FY2011$6.43B+17.9%10-K
FY2010$5.45B-12.4%10-K
FY2009$6.22B+6.6%10-K
FY2008$5.83B+5.0%10-K
FY2007$5.55B-22.4%10-K
FY2006$7.16B-10-K
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →